FIGO STAGE III-IV

Clinical trials for FIGO STAGE III-IV explained in plain language.

Never miss a new study

Get alerted when new FIGO STAGE III-IV trials appear

Sign up with your email to follow new studies for FIGO STAGE III-IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope to delay ovarian Cancer's return in High-Risk patients

Disease control Ongoing

This large, late-stage trial is testing whether a drug called olaparib can help keep advanced ovarian cancer from coming back after initial chemotherapy. It is for women with a specific genetic change (BRCA mutation) whose cancer responded well to first treatment. The study compa…

Matched conditions: FIGO STAGE III-IV

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

FIGO STAGE III-IV

Get alerted when new FIGO STAGE III-IV trials appear

New hope to delay ovarian Cancer's return in High-Risk patients